Lili Yao Selected Research

Lili Yao Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 01/2018
2	COVID-19 10/2023 - 09/2022
2	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 02/2020
2	Insulin Resistance 09/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2018
2	Infections 01/2021 - 01/2018
2	Carcinogenesis 02/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2012
2	Inflammation (Inflammations) 01/2016 - 01/2014
1	Vomiting 10/2023
1	Nausea 10/2023
1	Fever (Fevers) 10/2023
1	Acid-Base Imbalance 02/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Follicular Adenocarcinoma 01/2023
1	Common Cold 09/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022
1	Pneumonia (Pneumonitis) 03/2022
1	Hemorrhage 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Adenocarcinoma of Lung 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Ulcerative Colitis 01/2021
1	AIDS-Related Complex (ARC) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2019
1	Adenocarcinoma 09/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Body Weight (Weight, Body) 01/2016
1	Hyperglycemia 01/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 02/2012
3	EnzymesIBA 01/2018 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2020
2	pembrolizumabIBA 01/2023 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 09/2021 - 01/2020
2	Exenatide (Byetta)FDA Link 09/2021 - 01/2020
2	AcidsIBA 01/2021 - 02/2012
2	MicroRNAs (MicroRNA)IBA 02/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 02/2020 - 01/2004
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 04/2024
1	P-SelectinIBA 04/2024
1	polydopamineIBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 04/2024
1	VaccinesIBA 10/2023
1	C-Reactive ProteinIBA 10/2023
1	CyclinsIBA 03/2023
1	Sulfur DioxideIBA 02/2023
1	FluoridesIBA 02/2023
1	Sodium-Bicarbonate SymportersIBA 02/2023
1	Sodium Fluoride (Ossin)FDA Link 02/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	CREB-Binding ProteinIBA 01/2023
1	ElementsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2022
1	Rituximab (Mabthera)FDA Link 03/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2021
1	GasotransmittersIBA 11/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021
1	Long Noncoding RNAIBA 01/2021
1	CateninsIBA 01/2021
1	shenling baizhu sanIBA 01/2021
1	LipidsIBA 01/2021
1	Sterol Regulatory Element Binding ProteinsIBA 01/2021
1	WortmanninIBA 01/2021
1	fibroblast growth factor 21IBA 01/2020
1	isophane insulin lispro drug combination (25:75) insulin lisproIBA 01/2020
1	Monoamine Oxidase (MAO)IBA 01/2020
1	CopperIBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	SiliconIBA 01/2020
1	TitaniumIBA 01/2020
1	olutasidenibIBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 09/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2018
1	GlycogenIBA 01/2018
1	arseniteIBA 01/2018
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2018
1	Liver GlycogenIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	LeptinIBA 01/2016

Therapy/Procedure

5	Therapeutics 04/2024 - 09/2021
1	Drug Therapy (Chemotherapy) 04/2024
1	Oral Administration 03/2023
1	Neoadjuvant Therapy 01/2023
1	Patient Isolation 09/2022